Biostem Technologies Stock Today
| BSEM Stock | USD 9.36 0.12 1.30% |
Performance11 of 100
| Odds Of DistressLess than 9
|
Biostem Technologies is selling at 9.36 as of the 25th of April 2024; that is 1.30 percent increase since the beginning of the trading day. The stock's lowest day price was 9.09. Biostem Technologies has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Biostem Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of January 2024 and ending today, the 25th of April 2024. Click here to learn more.
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida. The company has 9.24 M outstanding shares. More on Biostem Technologies
Moving together with Biostem OTC Stock
| 0.61 | NVO | Novo Nordisk AS Earnings Call This Week | PairCorr |
Moving against Biostem OTC Stock
| 0.78 | WXIBF | WuXi Biologics | PairCorr |
| 0.73 | MCD | McDonalds Earnings Call This Week | PairCorr |
| 0.66 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.61 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
| 0.52 | INTC | Intel Earnings Call Today | PairCorr |
| 0.49 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.47 | CSCO | Cisco Systems Aggressive Push | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biostem OTC Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biostem Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biostem Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Marc Barhonovich |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Biostem Technologies [BSEM] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 34.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biostem Technologies's market, we take the total number of its shares issued and multiply it by Biostem Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biostem Technologies conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 9.24 M outstanding shares.
Biostem Technologies currently holds about 1.37 M in cash with (581.57 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Check Biostem Technologies Probability Of Bankruptcy
Biostem Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Biostem Technologies jumping above the current price in 90 days from now is about 52.73%. The Biostem Technologies probability density function shows the probability of Biostem Technologies otc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the otc stock has a beta coefficient of 1.6604 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Biostem Technologies will likely underperform. Additionally, biostem Technologies has an alpha of 0.7547, implying that it can generate a 0.75 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Biostem Technologies to move above the current price in 90 days from now is about 52.73 (This Biostem Technologies probability density function shows the probability of Biostem OTC Stock to fall within a particular range of prices over 90 days) .
Biostem Technologies Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biostem Technologies market risk premium is the additional return an investor will receive from holding Biostem Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biostem Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Biostem Technologies' alpha and beta are two of the key measurements used to evaluate Biostem Technologies' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.62 | |||
| Semi Deviation | 6.15 | |||
| Standard Deviation | 8.99 | |||
| Variance | 80.77 |
Biostem Stock Against Markets
Picking the right benchmark for Biostem Technologies otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biostem Technologies otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biostem Technologies is critical whether you are bullish or bearish towards Biostem Technologies at a given time. Please also check how Biostem Technologies' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biostem Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Biostem Technologies Corporate Directors
Biostem Technologies corporate directors refer to members of a Biostem Technologies board of directors. The board of directors generally takes responsibility for the Biostem Technologies' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biostem Technologies' board members must vote for the resolution. The Biostem Technologies board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Steven Velte | Director | Profile | |
| Jennie Sandqvist | Director | Profile | |
| Andrew VanVurst | COO Director | Profile | |
| Leon Willis | CFO, Secretary, Treasurer, Director | Profile |
How to buy Biostem OTC Stock?
Before investing in Biostem Technologies, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biostem Technologies. To buy Biostem Technologies stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biostem Technologies. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Biostem Technologies stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Biostem Technologies stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Biostem Technologies stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biostem Technologies, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Biostem Technologies?
The danger of trading Biostem Technologies is mainly related to its market volatility and OTC Stock specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biostem Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biostem Technologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biostem Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biostem Technologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Biostem Technologies information on this page should be used as a complementary analysis to other Biostem Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Biostem OTC Stock analysis
When running Biostem Technologies' price analysis, check to measure Biostem Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biostem Technologies is operating at the current time. Most of Biostem Technologies' value examination focuses on studying past and present price action to predict the probability of Biostem Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biostem Technologies' price. Additionally, you may evaluate how the addition of Biostem Technologies to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |